Navigation Links
Which Prostate Cancers Really Need Treatment?

MIAMI, July 9, 2013 /PRNewswire-iReach/ --, a leading website from Dr. Bert Vorstman, has recently posted a new article outlining which prostate cancers really need treatment.

"Most prostate cancers diagnosed are classed as the low or favorable-risk Gleason 6 (3+3) prostate cancer and the majority of these cancers behave like insignificant pseudo cancers, do not progress and do not need any treatment whether through focal therapy or whole gland treatment. 

"These cancers should simply be monitored through active surveillance", said Dr Vorstman, a Coral Springs Florida urologistwith over 30 years of experience in managing localized prostate cancer. In addition, Dr Vorstman warned that, "For many men, their road to debilitation and zero benefits began with the highly unreliable PSA prostate cancer screening blood test followed by the risky and painful office prostate biopsy. The finding of some insignificant prostate cancer was then license for misinformation, misrepresentation and falsehoods culminating in mismanagement and mistreatment. In fact, the risk of Gleason 6 (3+3) treatment harm is greater than the risk of the untreated insignificant prostate cancer." Dr Vorstman added, "Particularly disturbing is the gross overtreatment of most of these Gleason 6 (3+3) prostate cancers with the toxic, irreversible radical surgery/robotic prostatectomy for which there is no evidence based medicine support. This unproven, emasculating radical surgery/robotic prostatectomy for insignificant Gleason 6 (3+3) cancers represents "modern day" human experimentation. 

"At 20 years, these patients, or "sufferers" are survivors of their treatment, not survivors of their insignificant cancer." Furthermore said Dr Vorstman, "The gross overdiagnosis and overtreatment of this non aggressive prostate cancer and the insignificant number of lives saved by the crippling surgical treatment have been underscored by the embarrassing USPSTF report on prostate cancer screening as well as the flurry of class action lawsuits against the robot equipment makers. In response to these concerns there have been some moves by urologists to readdress prostate cancer screening guidelines and to tighten the indications for the use of the highly unreliable PSA blood test (the AUA now suggesting greatest evidence for "benefit" from routine screening was for men ages 55 to 69 only) as well as address the burning issue of prostate cancer overdiagnosis. Regrettably though, concerns regarding the pervasive overtreatment of insignificant Gleason 6 (3+3) prostate cancer with the irreversible, unproven, high-risk robotic prostatectomy are not being addressed."

Dr Vorstman's passion is the empowerment of men and their wives/partners about localized prostate cancer, management options and health choices. He is a dedicated patient advocate and an outspoken critic of overdiagnosis and overtreatment of the favorable-risk Gleason 6 (3+3) prostate cancer. His powerful messages and insights about prostate cancer reach many people through his website and blog,

To review Dr Vorstman's extensive writings on localized prostate cancer management go to, contact Dr Bert Vorstman at 877 783 4438 or,

Media Contact: Dr. Bert Vorstman, UrologyWeb, 954-752-3166,

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
2. Which plants will survive droughts, climate change?
3. Scientists uncover mechanism by which plants inherit epigenetic modifications
4. CSHL-led team discovers new way in which plants control flower production
5. Researchers identify proteins that indicate which kidney tumors are most likely to spread
6. Gladstone scientists discover novel mechanism by which calorie restriction influences longevity
7. Which nutritional factors help preserve muscle mass, strength and performance in seniors?
8. Video study shows which fish clean up coral reefs, showing importance of biodiversity
9. BUSM study reveals novel mechanism by which UVA contributes to photoaging of skin
10. Scientists sequence genome of sacred lotus, which likely holds anti-aging secrets
11. Mechanism discovered which aids Legionella to camouflage itself in the organism
Post Your Comments:
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology: